Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
EHC 2022
AES 2022
WSC 2022
ECTRIMS 2022
EHDN 2022
MDS 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Parkinson's Disease
6:36
The potential of nilotinib in the treatment of movement disorders
Charbel Moussa
• 28 Nov 2022
1:10
Updates on α-synuclein as a biomarker in Parkinson’s disease
Gennaro Pagano
• 17 Sep 2022
1:42
Development of novel trial outcomes in Parkinson’s disease
Gennaro Pagano
• 17 Sep 2022
1:33
Tackling sleep disturbances in Parkinson’s disease
Gennaro Pagano
• 17 Sep 2022
1:09
Prodromal Parkinson’s disease: identification & ethical issues
Gennaro Pagano
• 17 Sep 2022
3:36
Systems underlying music-induced paradoxical movement in Parkinson’s disease
Bin Hu
• 12 Sep 2022
0:53
Effects of apomorphine sublingual film on QT interval in patients with Parkinson’s disease
Fabrizio Stocchi
• 16 Sep 2022
1:04
Implementing device-aided treatment strategies in advanced Parkinson’s disease
Eric Freire-Alvarez
• 15 Sep 2022
0:50
Subcutaneous levodopa/carbidopa infusion for Parkinson’s disease
Eric Freire-Alvarez
• 15 Sep 2022
1:26
Targeting α-synuclein & neuroinflammation in Parkinson’s disease
Fabrizio Stocchi
• 16 Sep 2022
5:23
In-home remote assessment of the MDS-UPDRS Part III: development a guide for patients
Michelle Tosin
• 23 Sep 2022
4:22
Understanding patient perceptions of medication adherence in PD
Michelle Tosin
• 23 Sep 2022
2:47
α-synuclein & Parkinson’s disease: moving away from anti-α-synuclein approaches?
Alberto Espay
• 16 Sep 2022
5:15
New MDS task force on early-onset Parkinson’s disease
Rodolfo Savica
• 16 Sep 2022
1:14
Continuous dopaminergic stimulation: Advanced treatments in Parkinson’s disease
Per Odin
• 17 Sep 2022
1:39
Quality of life in patients with late-stage Parkinson’s disease
Per Odin
• 17 Sep 2022
1
2
3
4
5
…
28
Next